Teladoc Health Investor Presentation — January 2021

Document content

Enabling, delivering and empowering

global access to whole -person care

39th Annual J.P. Morgan Healthcare Conference

•© 2002 –2020 Teladoc Health, Inc. All rights reserved. Our mission is to empower all people

everywhere to live their healthiest lives

by transforming the healthcare experience.

Advanced data and analytics driving superior outcomes

Global leader across distribution channelsConsistent track record of revenue growth and margin improvement

Unmatched combination of expertise & advanced technology

across the continuum of care

Multiple levers for growthMembers & Visits (millions)(1)

1.0m 1.5m2.6m4.1m10.6m

12.1m19.6m22.8m36.7m50 to 51m

2016 2017 2018 2019 2020ERevenue ($ millions)

Operating cash flow ($ millions) Adj. EBITDA ($ millions)(2)

-$40m-$13m$13m$32m$110 to $113m

2016 2017 2018 2019 2020E$123m$233m$418m$553m$1,091 to $1,093m

2016 2017 2018 2019 2020E

-$52m-$34m-$5m$30m$61m

2016 2017 2018 2019 YTD 3Q20

1. Excludes 22m VFO populations.

2. See adjusted EBITDA reconciliation immediately following this presentation.>80%

CAGR70M+U.S. lives with access

Health solutions11K+Care locations as of 4Q20 540K+People with chronic

conditions served as of

10.6MVisits delivered by

clinicians & therapists

in 20203.5M+Visits enabled by

solutions in 20201B+Member data points

>40%Fortune 500 companies

Preview truncated — download the full document for the complete content.